Benchmark Holdings (BMK) interim results presentation to analysts.

Trond Willikson, CEO and Septima Maguire, CFO present the H1 results, the strategy and the outlook. Trond Willikson, CEO 00:18 Introduction 00:59 H1 2021 Highlights Septima Maguire, CFO 08:17 Financial highlights Trond Willikson, CEO 14:40 FY21 Outlook Benchmark Holdings plc is engaged in the provision of aquaculture health, genetics and nutrition. The Company’s segments include genetics, advanced nutrition and health. The Company develops products that helps fish and shrimp to improve their sustainability and profitability by improving yield, quality, and by reducing mortality. The Company’s products include high genetic quality ova for salmon, shrimp and tilapia, and breeding, program, specialist feeds for early stage shrimp and fish; probiotics, biocides and medicines.